Novel Approaches in Metronomic Chemotherapy for Breast Cancer Treatment

1. Auflage 2024
ISBN: 978-1-03-262045-9
Verlag: Taylor & Francis Ltd

Buch, Englisch, 208 Seiten, Format (B × H): 178 mm x 254 mm

This book provides the latest research and developments in the field of metronomic chemotherapy for breast cancer. It presents the principles and mechanisms of metronomic chemotherapy, preclinical and clinical studies, and the latest developments in drug delivery systems and nanoformulations. The clinical pharmacology of metronomic chemotherapy, including pharmacokinetics, pharmacogenetics, pharmacoeconomics, and adverse drug reactions, are also examined.

Key Features:

- Introduces metronomics therapy in the neoadjuvant and adjuvant treatment of breast cancer

- Explores the potential of metronomics in terms of personalized chemotherapy

- Present pharmacological bases of metronomic chemotherapy

- Covers the latest developments in drug delivery systems, nanotechnology, and nanoformulations

- Discusses antiangiogenic effects and the impact of metronomics on immunity

This book is useful for students, researchers, oncologists, pharmacologists, and healthcare experts interested in understanding the clinical potential of metronomic chemotherapy in breast cancer.

Zielgruppe

Academic and Professional Reference

Autoren/Hrsg.

Mir, Manzoor Ahmad

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Pflege Fachpflege
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Onkologie, Krebsforschung
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Chemotherapie
• Technische Wissenschaften Verfahrenstechnik | Chemieingenieurwesen | Biotechnologie Biotechnologie Medizinische Biotechnologie

Inhaltsverzeichnis

Chapter 1 Introduction to metronomic chemotherapy

Chapter 2 Metronomic chemotherapy- a multi-targeted therapy             

Chapter 3 Conventional chemotherapeutic vs. metronomic chemotherapy           

Chapter 4 The anti-angiogenic basis of metronomic chemotherapy        

Chapter 5 Imaging techniques, biomarkers, and methods for metronomic chemotherapy

Chapter 6 Metronomic chemotherapy in breast cancer

Chapter 7 Metronomic chemotherapy in combination with anticancer vaccines   

Chapter 8 Metronomic: towards personalized chemotherapy   

Chapter 9 Metronomic chemotherapy for metastatic breast cancer         

Chapter 10 Recent Advances, challenges, and future of metronomic chemotherapy             

Chapter 11 Targeted therapies in combination with metronomic chemotherapy   

Chapter 12 Recent advances in metronomic chemotherapy: nanotechnology-based low-dose chemotherapy in breast cancer

Index

Über Autor(innen)

Dr. Manzoor Ahmad Mir holds Master’s Degree in Zoology with Gold Medal from HNBG Central University and after qualifying prestigious National level CSIR-JRF-NET examination; he worked jointly for his PhD at Jawaharlal Nehru University New Delhi and CSIR-Institute of Microbial Technology Chandigarh in the field of Immunopathology. His basic research interests include, molecular immunology and Immunobiology of microbes (MTB). His PhD research title was “Role of co-stimulation in the survival of intracellular pathogens”. He currently teaches Cancer Biology, and Immunology at the Department of Bioresources, School of Biological Sciences, University of Kashmir. He is presently heading the Department of Bioresources, University of Kashmir.